Portfolio company
ZipBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops artificial intelligence to design gene therapies for pharmaceutical firms and biotechnology researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Dyno Therapeutics
The company designs adeno-associated virus vectors for gene delivery using artificial intelligence for biopharmaceutical and pharmaceutical partners.
Nanograb
This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
Cassidy Bio
This company develops an AI foundation model to design gene editing therapies and prediction tools for pharmaceutical partners and researchers.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
Creyon Bio
This company develops AI-designed oligonucleotide-based medicines and RNA-targeted therapies for pharmaceutical partners and patients with neuromuscular and immunological diseases.
Stridebio
This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.
